Competitors
| Companies | Market Cap | G | R | O | W | T | H |
|---|---|---|---|---|---|---|---|
|
Allergan NYSE:AGN |
63,79 B | 0,00% | 0,00% | 0,00% | 0,00% | DOWN | |
|
Jazz Pharmaceuticals NasdaqGS:JAZZ |
11,51 B | 8,10% | 2/6 | 79,55% | -54,33% | 20,62% | UP |
|
Alkermes NasdaqGS:ALKS |
5,79 B | 18,29% | 5/6 | 17,01% | 15,58% | 23,42% | DOWN |
|
Glanbia ISE:GL9 |
4,07 B | 4,55% | 5/6 | 5,11% | -26,83% | 11,98% | UP |
|
Avadel Pharmaceuticals NasdaqGM:AVDL |
2,12 B | 6,52% | 3/6 | 26,48% | -64,98% | -100,00% | UP |
|
Perrigo NYSE:PRGO |
1,49 B | -5,73% | 0/6 | -11,32% | 64,90% | 52,07% | DOWN |
|
Mallinckrodt OTCPK:MNK |
1,02 B | 0,00% | 3/4 | 0,00% | 0,00% | -100,00% | DOWN |
|
GH Research PLC NasdaqGM:GHRS |
0,90 B | 0,00% | 0/4 | 0,00% | 0,00% | 150,51% | DOWN |
|
Amryt Pharma NasdaqGM:AMYT |
0,47 B | 24,85% | 0/0 | 0,00% | 0,00% | 0,00% | DOWN |
|
Amarin NasdaqCM:AMRN |
0,31 B | -7,83% | 1/6 | -295,06% | -570,76% | -18,59% | DOWN |
|
Ovoca Bio AIM:OVB |
0,00 B | 0,00% | 2/2 | 0,00% | 0,00% | -100,00% | DOWN |
